BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33165070)

  • 21. Vaginal laser therapy for genitourinary syndrome of menopause - systematic review.
    Mension E; Alonso I; Tortajada M; Matas I; Gómez S; Ribera L; Anglès S; Castelo-Branco C
    Maturitas; 2022 Feb; 156():37-59. PubMed ID: 34217581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lasers in the era of evidence-based medicine.
    Hillard TC
    Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.
    Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z
    Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.
    Mounir DM; Hernandez N; Gonzalez RR
    Urology; 2021 May; 151():2-7. PubMed ID: 32966821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review.
    Moccia F; Pentangelo P; Ceccaroni A; Raffone A; Losco L; Alfano C
    Aesthetic Plast Surg; 2023 Dec; 47(6):2788-2799. PubMed ID: 37580562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here.
    Zipper R; Lamvu G
    J Comp Eff Res; 2022 Aug; 11(11):843-851. PubMed ID: 35726603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal rejuvenation: whose turf?
    Schilling L; Saedi N
    Semin Cutan Med Surg; 2018 Dec; 37(4):236-237. PubMed ID: 30475934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Device-based treatment for vaginal wellness.
    Alexiades M
    Semin Cutan Med Surg; 2018 Dec; 37(4):226-232. PubMed ID: 30475926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.
    Arunkalaivanan A; Kaur H; Onuma O
    Int Urogynecol J; 2017 May; 28(5):681-685. PubMed ID: 28154914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
    Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
    BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genitourinary syndrome of menopause and the use of laser therapy.
    Hutchinson-Colas J; Segal S
    Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light and energy-based therapeutics for genitourinary applications: Consensus on protocols and best practices.
    Alexiades MR; Iglesias C; Sokol E; Gaspar A; Tadir Y
    Lasers Surg Med; 2023 Jul; 55(5):444-454. PubMed ID: 37130435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vulvo-vaginal rejuvenation: Fact or fiction? Fractional carbon dioxide laser for genitourinary syndrome of menopause.
    Harris V; Dickison P; Lim A; Fischer G
    Australas J Dermatol; 2018 Nov; 59(4):341-343. PubMed ID: 29336007
    [No Abstract]   [Full Text] [Related]  

  • 38. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
    The NAMS 2020 GSM Position Statement Editorial Panel
    Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No. 358-Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence.
    Walter JE; Larochelle A
    J Obstet Gynaecol Can; 2018 Apr; 40(4):503-511. PubMed ID: 29680080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies.
    Tadir Y; Gaspar A; Lev-Sagie A; Alexiades M; Alinsod R; Bader A; Calligaro A; Elias JA; Gambaciani M; Gaviria JE; Iglesia CB; Selih-Martinec K; Mwesigwa PL; Ogrinc UB; Salvatore S; Scollo P; Zerbinati N; Nelson JS
    Lasers Surg Med; 2017 Feb; 49(2):137-159. PubMed ID: 28220946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.